Interleukin-5 receptor (IL-5R) ligands comprising amino sequences of formula TGGGDGYVX.sub.3VE X.sub.4 ARCPTCK, EGYVX.sub.3VE X.sub.4 ARCPTCK, EGYVX.sub.3VE X.sub.4 ARCPTCR, GYVX.sub.3VE X.sub.4 ARCPTCG, EGYVX.sub.3VE X.sub.4 ARCPTCG, GYVX.sub.3VE X.sub.4 ARCPTCR, and EGYVX.sub.3VE X.sub.4 AACPTCR, and methods of using the same, are described and claimed.

 
Web www.patentalert.com

< Method of controlling the binding of calmyrin to presenilin

< Methods for forming regional tissue adherent barriers and drug delivery systems

> Method for diagnosing an adenocarcinoma or a benign prostate pathology

> Tenascin-C isoform as marker for neoplasias
~ 00286